File #: A 21-513    Name: Medtronic Carelink Agreement
Type: BoS Agreement Status: Passed - Natividad Medical Center
File created: 10/12/2021 In control: Board of Supervisors
On agenda: 12/7/2021 Final action: 12/7/2021
Title: a. Authorize the Interim Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute a no-cost agreement with Medtronic USA, Inc. for remote monitoring of cardiac devices with an agreement term of December 1, 2021 through November 30, 2024. b. Approve the Interim Chief Executive Officer's recommendation to accept non-standard indemnification, limitations on liability, and limitations on damages provisions within the agreement.
Attachments: 1. Board Report.pdf, 2. Medtronic Carelink Agreement, 3. Board Report rev - CLEAN, 4. Board Report rev - REDLINE, 5. Completed Board Order Item No. 27
Title
a. Authorize the Interim Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute a no-cost agreement with Medtronic USA, Inc. for remote monitoring of cardiac devices with an agreement term of December 1, 2021 through November 30, 2024.
b. Approve the Interim Chief Executive Officer's recommendation to accept non-standard indemnification, limitations on liability, and limitations on damages provisions within the agreement.

Report
RECOMMENDATION:

It is recommended the Board of Supervisors:

a. Authorize the Interim Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute a no-cost agreement with Medtronic USA, Inc. for remote monitoring of cardiac devices with an agreement term of December 1, 2021 through November 30, 2024.
b. Approve the Interim Chief Executive Officer's recommendation to accept non-standard indemnification, limitations on liability, and limitations on damages provisions within the agreement.

SUMMARY/DISCUSSION:

The purpose of this agreement is to provide mobile tablets to Natividad Medical Center at no charge. These tablets provide programed information for analysis of a patient's pacemaker or defibrillator from the Medtronic Company. This new technology is replacing antiquated manual analysis requiring a representative come in to provide the service.

The advantage is a win-win for the Medical Center in the following ways:

a) The small tablet (about the size of an IPAD) now replaces a 25-30 lbs device.
b) The patient is no longer connected to external leads or wires directly to the Medtronic device.
c) The mobile tablet is placed near any patient, and then automatically provides the analysis of the internal Medtronic implanted device.
d) The software will contact the company and the representative as well as the physician to report the findings of the tablet.
e) The device can come to the patient anywhere in the hospital rather than requiring the patient to come to th...

Click here for full text